Transgenic mice over-expressing the human ENPP1 driven by the CMV promoter had hyperglycemia and hyperinsulinemia with impaired glucose tolerance test, and reduced glucose uptake in the muscle (18). The gene discussed is ENPP1; the disease is hyperinsulinism.